Stronger Sell Today ATRS ranks #4386 as SELL CANDIDATE. Weaker Sell
Today ATRS ranks #4386 as SELL CANDIDATE.

ATRS stock Antares Pharma

ATRS stock
Antares Pharma

April 24, 2019
Change -2.13%
Chart period: 2019-01-25 - 2019-04-24
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Will ATRS stock price go up or down on Thu, 25 Apr 2019?

Antares Pharma Forecast and Stock Analysis

Technical ATRS stock analysis for April 24, 2019.

Sell candidate since 2019-03-21 Loss -16.62%
Shorts n/a
Cash n/a
Loans n/a
Beta 1.05
ROA -8.17

Antares Pharma fell by -2.13% in the last day from $2.82 to $2.76 The price has fallen in 6 of the last 10 days and is down by -5.8% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -158 439 shares and in total 441 564 shares bought and sold for approximately $1.22 million.

Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the ATRS stock was $2.76. This is 2.13% less than the trading day before Tuesday, 23rd Apr 2019.

During day the stock fluctuated 4.26% from a day low at $2.75 to a day high of $2.87.

30 day high of the ATRS stock price was $3.14 and low was $2.60.
90 day high was $3.96 and low was $2.60.
52 week high for the Antares Pharma - $3.96 and low - $2.16.

Trend

Antares Pharma lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.60 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.06% during the next 3 months and, with 90% probability hold a price between $2.34 and $3.29 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Antares Pharma holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.76 and $3.13. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 38 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Antares Pharma finds support from accumulated volume at $2.75.

Support: $2.75 Price: $2.76 Resistance: $2.99

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.12 between high and low, or 4.26%. For the last week the stock has had a daily average volatility of 5.28%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Stronger Sell Today ATRS ranks #4386 as SELL CANDIDATE. Weaker Sell
Today ATRS ranks #4386 as SELL CANDIDATE.